Castle Biosciences, Inc. (CSTL)
33.47
-0.73
(-2.13%)
USD |
NASDAQ |
Aug 24, 16:00
33.50
+0.03
(+0.09%)
After-Hours: 20:00
Castle Biosciences Total Assets (Quarterly) : 561.18M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 561.18M |
| March 31, 2026 | 547.80M |
| December 31, 2025 | 609.21M |
| September 30, 2025 | 562.79M |
| June 30, 2025 | 544.73M |
| March 31, 2025 | 501.72M |
| December 31, 2024 | 553.92M |
| September 30, 2024 | 514.56M |
| June 30, 2024 | 487.31M |
| March 31, 2024 | 458.51M |
| December 31, 2023 | 477.81M |
| September 30, 2023 | 436.02M |
| June 30, 2023 | 425.40M |
| March 31, 2023 | 426.89M |
| December 31, 2022 | 474.02M |
| Date | Value |
|---|---|
| September 30, 2022 | 457.81M |
| June 30, 2022 | 458.38M |
| March 31, 2022 | 444.42M |
| December 31, 2021 | 462.57M |
| September 30, 2021 | 433.69M |
| June 30, 2021 | 435.53M |
| March 31, 2021 | 437.33M |
| December 31, 2020 | 439.33M |
| September 30, 2020 | 210.39M |
| June 30, 2020 | 201.55M |
| March 31, 2020 | 120.26M |
| December 31, 2019 | 119.75M |
| September 30, 2019 | 113.20M |
| June 30, 2019 | 33.35M |
| March 31, 2019 | 30.97M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| RadNet, Inc. | 4.226B |
| Lumexa Imaging Holdings, Inc. | 1.809B |
| Labcorp Holdings, Inc. | 18.53B |
| Quest Diagnostics, Inc. | 16.94B |
| OPKO Health, Inc. | 1.829B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 91.15M |
| Shareholders Equity (Quarterly) | 470.03M |
| Debt to Equity Ratio | 0.078 |
| Current Ratio | 6.036 |
| Net Debt Paydown Yield | -0.30% |